185 related articles for article (PubMed ID: 38489693)
1. Establishment and validation of nomograms to predict the overall survival and cancer-specific survival for non-metastatic bladder cancer patients: A large population-based cohort study and external validation.
Li S; Wang J; Zhang Z; Wu Y; Liu Z; Yin Z; Liu J; He D
Medicine (Baltimore); 2024 Mar; 103(11):e37492. PubMed ID: 38489693
[TBL] [Abstract][Full Text] [Related]
2. Development and Validation of Nomograms to Predict Cancer-Specific Survival and Overall Survival in Elderly Patients With Prostate Cancer: A Population-Based Study.
Zhang Z; Zhanghuang C; Wang J; Tian X; Wu X; Li M; Mi T; Liu J; Jin L; Li M; He D
Front Oncol; 2022; 12():918780. PubMed ID: 35814387
[TBL] [Abstract][Full Text] [Related]
3. The nomograms for predicting overall and cancer-specific survival in elderly patients with early-stage lung cancer: A population-based study using SEER database.
Yu G; Liu X; Li Y; Zhang Y; Yan R; Zhu L; Wang Z
Front Public Health; 2022; 10():946299. PubMed ID: 36159305
[TBL] [Abstract][Full Text] [Related]
4. Establishment and validation of nomogram models for overall survival and cancer-specific survival in spindle cell sarcoma patients.
Qi W; Ren Y; Wang H; Wan Y; Wang D; Yao J; Pan H
Sci Rep; 2023 Dec; 13(1):23018. PubMed ID: 38155261
[TBL] [Abstract][Full Text] [Related]
5. Bladder cancer survival nomogram: Development and validation of a prediction tool, using the SEER and TCGA databases.
Zhang Y; Hong YK; Zhuang DW; He XJ; Lin ME
Medicine (Baltimore); 2019 Nov; 98(44):e17725. PubMed ID: 31689813
[TBL] [Abstract][Full Text] [Related]
6. Establishment and validation of systematic prognostic nomograms in patients over 60 years of age with osteosarcoma: A multicenter external verification study.
Shao Z; Li J; Liu Z; Bi S
Cancer Med; 2023 Apr; 12(8):9589-9603. PubMed ID: 36992547
[TBL] [Abstract][Full Text] [Related]
7. Nomograms and scoring system for forecasting overall and cancer-specific survival of patients with prostate cancer.
Zhou Y; Lin C; Zhu L; Zhang R; Cheng L; Chang Y
Cancer Med; 2023 Feb; 12(3):2600-2613. PubMed ID: 35993499
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of survival nomograms for patients with differentiated thyroid cancer with distant metastases: a SEER Program-based study.
Ma Q; Chen Z; Fang Y; Wei X; Wang N; Zhou X; Li S; Ying C
J Endocrinol Invest; 2024 Jan; 47(1):115-129. PubMed ID: 37294407
[TBL] [Abstract][Full Text] [Related]
9. Survival nomograms for patients with retroperitoneal soft tissue sarcoma based on the SEER database and an external cohort.
Wu J; Zhang Y; Yao G; Tuersunmaimaiti A; Azhati Y; Mamuti A; Wen H; Tuxun T
J Cancer Res Clin Oncol; 2023 Nov; 149(16):15013-15026. PubMed ID: 37610674
[TBL] [Abstract][Full Text] [Related]
10. Prognostic nomogram based on the lymph node metastasis indicators for patients with bladder cancer: A SEER population-based study and external validation.
Li S; Wang Y; Hu X
Cancer Med; 2023 Mar; 12(6):6853-6866. PubMed ID: 36479835
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of surgery and radiotherapy in elderly patients with localized prostate cancer: establishing and time-based external validation a nomogram from SEER-based study.
Zhanghuang C; Zhu J; Li Y; Wang J; Ma J; Li L; Yao Z; Ji F; Wu C; Tang H; Xie Y; Yan B; Yang Z
BMC Urol; 2024 Jan; 24(1):12. PubMed ID: 38184526
[TBL] [Abstract][Full Text] [Related]
12. Identifying the Prognosis Factors and Predicting the Survival Probability in Patients with Non-Metastatic Chondrosarcoma from the SEER Database.
Huang R; Sun Z; Zheng H; Yan P; Hu P; Yin H; Zhang J; Meng T; Huang Z
Orthop Surg; 2019 Oct; 11(5):801-810. PubMed ID: 31663279
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a nomogram to predict the prognosis of patients with gastric cardia cancer.
Shi X; Xu L; Ma B; Wang S
Sci Rep; 2020 Aug; 10(1):14143. PubMed ID: 32839498
[TBL] [Abstract][Full Text] [Related]
14. Surveillance of prognostic risk factors in patients with SCCB using artificial intelligence: a retrospective study.
Zhanghuang C; Zhang Z; Wang J; Yao Z; Ji F; Wu C; Ma J; Yang Z; Xie Y; Tang H; Yan B
Sci Rep; 2023 May; 13(1):8727. PubMed ID: 37253772
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a nomogram to predict long-term cancer-specific survival for patients with osteosarcoma.
Yu Y; Wang S; Liu J; Ge J; Guan H
Sci Rep; 2023 Jun; 13(1):10230. PubMed ID: 37353555
[TBL] [Abstract][Full Text] [Related]
16. Nomograms for predicting survival in patients with micropapillary bladder cancer: a real-world analysis based on the surveillance, epidemiology, and end results database and external validation in a tertiary center.
Liu P; Xu L; Chen G; Shi B; Zhang Q; Chen S
BMC Urol; 2023 Feb; 23(1):16. PubMed ID: 36782165
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Nomograms for Patients with Primary Sarcomatoid Carcinoma of The Urinary Bladder: Based on The SEER Database.
Xu C; Xiong B
Urol J; 2024 Mar; 21(2):87-97. PubMed ID: 37245087
[TBL] [Abstract][Full Text] [Related]
18. Establishment and validation of a postoperative predictive model for patients with colorectal mucinous adenocarcinoma.
Wang P; Song Q; Lu M; Xia Q; Wang Z; Zhao Q; Ma X
World J Surg Oncol; 2022 Oct; 20(1):330. PubMed ID: 36192778
[TBL] [Abstract][Full Text] [Related]
19. Nomograms predicting the overall survival and cancer-specific survival of patients with stage IIIC1 cervical cancer.
Feng Y; Wang Y; Xie Y; Wu S; Li Y; Li M
BMC Cancer; 2021 Apr; 21(1):450. PubMed ID: 33892663
[TBL] [Abstract][Full Text] [Related]
20. Development and Validation of Prognostic Nomograms to Predict Overall and Cancer-Specific Survival for Patients with Adenocarcinoma of the Urinary Bladder: A Population-Based Study.
Yang Z; Bai Y; Liu M; Hu X; Han P
J Invest Surg; 2022 Jan; 35(1):30-37. PubMed ID: 32851885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
